These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2379797)

  • 21. Dopamine dependent behaviours in rats with bilateral ibotenic acid-induced lesions of the globus pallidus.
    Avdelidis D; Spyraki C
    Brain Res Bull; 1986 Jan; 16(1):25-32. PubMed ID: 3513907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
    Pycock C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central effects of angiotensin II, its fragment and analogues.
    Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
    Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of carbaryl on some dopaminergic behaviors in rats.
    Rigon AR; Reis M; Takahashi RN
    Gen Pharmacol; 1994 Oct; 25(6):1263-7. PubMed ID: 7875555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
    Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
    Yamaguchi K; Nabeshima T; Amano M; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1985 Nov; 23(5):803-9. PubMed ID: 4080767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation.
    Elazar Z; Ganchrow D; Paz M; Rabinowitz R; Paz Z; Korczyn AD
    Neurosci Lett; 1990 Nov; 119(2):245-8. PubMed ID: 1980731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
    Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.